Xellia Pharms Aps Company Profile
✉ Email this page to a colleague
What is the competitive landscape for XELLIA PHARMS APS
XELLIA PHARMS APS has ten approved drugs.
Summary for Xellia Pharms Aps
| US Patents: | 0 |
| Tradenames: | 8 |
| Ingredients: | 8 |
| NDAs: | 10 |
Drugs and US Patents for Xellia Pharms Aps
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xellia Pharms Aps | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 202766-001 | Jan 15, 2014 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Xellia Pharms Aps | CASPOFUNGIN ACETATE | caspofungin acetate | POWDER;INTRAVENOUS | 205923-001 | Jul 2, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Xellia Pharms Aps | TIGECYCLINE | tigecycline | POWDER;INTRAVENOUS | 205722-001 | Oct 18, 2019 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
